>>MSCI – Two additions to MSCI Indonesia: Charoen Pokphand Indonesia (CPIN) and Kalbe Farma (KLBF). Estimated buying volume for CPIN is 43.5mn shares, for KLBF is 133mn shares.>>>
"إِنَّا مَكَّنَّا لَهُۥ فِى ٱلْأَرْضِ وَءَاتَيْنَهُ مِن كُلِّ شَىْءٍۢ سَبَبًۭا فَأَتْبَعَ سَبَبًا Sesungguhnya Kami telah memberi kekuasaan kepadanya di (muka) bumi, dan Kami telah memberikan kepadanya jalan (untuk mencapai) segala sesuatu, maka diapun menempuh suatu jalan." (QS. AL KAHFI:84-85)
>> Saham Agung Podomoro Dilepas Rp365 per Unit >>> INDY: After mkt close the major shareholders placed out a USD 200m block of stock, or about 10% of cap at 3675 (range 3600-3725) at a 5.7% discount. The placement was said to be 3X subscribed to.

My Family

Selasa, 17 Februari 2009

UBS Bank Danamon Indo Rating: Buy Target: Rp2,775

Bank Danamon Indo Rating: Buy Target: Rp2,775 Price: Rp2,225 RIC: BDMN.JK
Prior: Sell Prior: Rp2,200 Mkt Cap: Rp11,037bn BBG: BDMN IJ


We upgrade our rating from Sell to Buy for three reasons:
1) The bank is not going in for the rights issue to fix problems with the balance sheet quality;
2) it is doing the rights issue for the right reason—to comply with the Basel 2 operational risk standards, to improve its competitive positioning relative to other big banks, and to invest in high-growth businesses; and 3) its valuation on a post-rights basis is attractive at 0.9x P/BV, reflecting a lot

Q408 results indicate strong earnings power to withstand NPL shock
The bank recorded around 4% pre-provision ROA in Q408. This should be adequate to withstand the expected increase in credit cost in 2009. We believe Danamon needs around US$400m to bring its capital adequacy ratio (CAR) to 14-15% by end-2009. This includes the capital impact from the Basel 2 implementation, and the investment in Adira and calling in its subdebt.

The valuation is also attractive on a 12m forward post-rights basis
Using a scenario of a US$400m rights issue at a 40% discount to the market, we arrive at a post-rights 12m forward valuation of 8.4x 2010E PE for Danamon. This is attractive both on a historical basis as well as a comparison basis. The stock would trade at 0.9x 2010E P/BV, which is the least expensive among the banks we cover.

Valuation: raise price target from Rp2,200 to Rp2,775
We derive our price target of Rp2,775 using the Gordon Growth model on a post-rights basis. We assume 20% return on equity (previously 17%) and 18.3% cost of equity to arrive at the target P/BV multiple. We apply the multiple to 2010 BVPS which we then discount a year to arrive at the price target.

Tidak ada komentar:

Posting Komentar

Yahoo! Finance: Top Stories

Reuters: Business News

Insider Stories

CNBC Top News and Analysis

» Ekobiz

The Wall Street Journal

AnggunTraders.com

Commodity Online Metals News

Britama.com

Palm Oil Prices

Commodities-Markets-The Economic Times

Detikfinance

BusinessWeek.com -- Top News

Palm Oil HQ Daily Update

Business Times : marketwatch

VIVAnews - BISNIS

The Star Online: Business

Inilah.com -

Latest financial news - CNNMoney.com

Tempointeraktif.com - Bisnis

ChinaDaily > bizchina

Sindikasi economy.okezone.com

Commodity News

Bursa Rumor - Tempatnya Investor Saham Cari Berita

Financial Times - Financial markets news

Hellenic Shipping News

ANTARA - Ekonomi & Bisnis

Industrial Metals & Minerals Industry News

Republika Online - Ekonomi

Yahoo Commodities News